Health Condition 1: N944- Primary dysmenorrhea
Conditions
Interventions
Intervention1: Validated integrated yoga intervention: Experimental group will receive 60 min structured yoga sessions of validated yoga protocol by certified
yoga therapist, 3 times in a week for 8 w
Sponsors
Dr Sanjib Kumar Patra
Eligibility
Inclusion criteria
Inclusion criteria: The study will include women aged 18-26 with regular menstrual cycles (21-35 days) and a clinical diagnosis of primary dysmenorrhea. Participants must experience moderate to severe menstrual pain along with symptoms like headaches, nausea, and vomiting, with pain onset 6-12 hours after menstruation begins and lasting 8-72 hours. They must experience at least 4 consecutive painful periods in the past six months. Participants must be healthy with no major chronic illnesses and no regular yoga practice in the last six months, and they must provide written informed consent.
Exclusion criteria
Exclusion criteria: women with secondary dysmenorrhea or significant gastrointestinal, gynaecological or autoimmune disease or gynaecological surgery, or, those using hormonal contraceptives or medications that could affect the menstrual cycle or pain perception.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Protaglandins Progestrone TNF alpha Interluekin(IL6 and IL 1 beta) and Pain intensityTimepoint: At Baseline and after 8 week of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Pain outcomes including primary dysmenorrhea severity will assess through WaLIDD Scale,and associated symptoms through Cox Menstrual Symptom Scale (CMSS) 2.Autonomic measures such as Short-term HRV via Biopac MP36. 3. Cognitive functions via PEBEL software includes variables such as Selective attention, Sustained attention, Working memory and Executive function. 4. Psychosocial measures includes Menstrual Distress Questionnaire (MEDI-Q), Depression, Anxiety and Stress Scale (DASS-21), Pain Catastrophizing Scale (PCS), Health-Related Productivity Questionnaire (HRPQ), Quality of Life Enjoyment and Satisfaction Questionnaire-short form (Q-LES-Q-SF), Functional and Emotional Measure of Dysmenorrhea (FEMD), Sleep Quality (Pittsburgh Sleep quality index) and World Health Organization Quality of life scale (WHOQOL-BREF) Timepoint: At Baseline and after 8 week of intervention | — |
Countries
India
Contacts
Public ContactDr Sanjib K Patra
Central University of Rajasthan
Outcome results
None listed